Winthrop Partners - WNY’s Pfizer PFE Stock Holding History

Winthrop Partners - WNY’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.01M	Buy	88,413 +3,035	+4%	+$110K	2.04%	10
2019 Q2	$3.51M	Buy	85,378 +4,816	+6%	+$191K	2.63%	7
2019 Q1	$3.27M	Buy	80,562 +4,498	+6%	+$180K	2.55%	7
2018 Q4	$3.15M	Sell	76,064 -142	-0.2%	-$5.89K	2.94%	6
2018 Q3	$3.19M	Buy	76,206 +3,725	+5%	+$143K	2.58%	4
2018 Q2	$2.49M	Buy	72,481 +65,369	+919%	+$2.23M	2.08%	8
2018 Q1	$2.38M	Sell	7,112 -63,498	-90%	-$2.18M	1.84%	10
2017 Q4	$2.46M	Buy	+70,610	New	+$2.41M	2.01%	10

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Winthrop Partners - WNY's PFE Position: Q3 2019 in Review

Winthrop Partners - WNY increased its Pfizer (PFE) stake by 3.6% in Q3 2019, buying an estimated $110K and bringing the position to 88,413 shares worth $3.01M. The position accounts for 2.04% of the portfolio, ranked #10.

Winthrop Partners - WNY first reported a position in PFE in Q4 2017 and has held it in 8 quarters since. The position peaked at $3.51M in Q2 2019. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

Winthrop Partners - WNY held 88,413 shares of Pfizer worth $3.01M as of Q3 2019.
Winthrop Partners - WNY bought 3,035 Pfizer shares in Q3 2019, an estimated $110K.
Pfizer made up 2.04% of Winthrop Partners - WNY's portfolio in Q3 2019, its #10 holding.
Winthrop Partners - WNY first reported a position in Pfizer in Q4 2017 and has held it in 8 quarters since.
Winthrop Partners - WNY's Pfizer position peaked at $3.51M in Q2 2019.
2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.